Cryogene sarl is a privately owned Lebanon-based company founded in 2004, whose scope of activity is mainly specialized medical services. Cryogene sarl is now offering its services in many countries in the region such as Lebanon, Cyprus, Kuwait, UAE, Saudi Arabia and Jordan. Cryogene sarl was the first company to promote cord blood stem cell banking in the Middle East. Since 2004, Cryogene sarl has been the sole agent for “Smart Cells International Ltd” (London, United Kingdom), UK leader in cord blood banking. Cryogene sarl expanded its activity to specialized laboratory testing and advanced diagnosis in women’s health through collaboration with “The Doctors Laboratory” in the United Kingdom. Cryogene sarl, through its network of gynecologists and hospitals, has developed an additional service following collaboration with the German laboratory “Cenata”, with its Non-Invasive Prenatal Testing. More recently, Cryogene sarl has been exclusively distributing “Natera Inc” prenatal diagnostic tests, as part of its continuous vision of pursuing excellence in selecting the most advanced tests to serve its patients. Cryogene sarl is also offering a recent tool in Medical Oncology, known as Tumor Profiling, performed by “Paradigm Dx” in the United States. Cryogene sarl is representing “Paradigm Dx” in the Middle East area. In the same line, Cryogene sarl is the sole distributor of Mammaprint by “Agendia”, a widely used genetic test for risk stratification of breast cancer patients. Cryogene sarl portfolio also includes 4K score test, the advanced risk assessment test for prostate cancer exclusively performed at “BioReference” in the United States. Cryogene sarl is pursuing its involvement in genetic analysis and is providing genetic panels for the diagnosis of diseases for different medical specialities. Those analysis are performed in major accredited genetic laboratories in Europe and USA to better serve the medical community in its daily practice.
